Population
Spontaneously hypertensive rats and Dahl salt-sensitive rats matched for blood pressure and age, along with…
Comparison
Antihypertensive therapy consisting of an… vs Normotensive counterparts and untreated…
Design
Preclinical
Authors
Loading...
May explain variable hypertensive end-organ damage; leaves open cNOS modulation as therapeutic target pending human studies.
Upregulation of vascular cNOS activity appears to have a protective cardiovascular homeostatic role in hypertension, potentially explaining variable end-organ disease severity among individuals with similar blood pressure levels.
Hayakawa et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: